Prevelance, Predictors and Outcome of Sepsis Associated Liver Injury (SALI)
Not yet recruiting
- Conditions
- Liver Injuries
- Registration Number
- NCT06758908
- Lead Sponsor
- Assiut University
- Brief Summary
prevelance, predictors and outcome of sepsis associated liver injury (SALI)
- Detailed Description
patient with liver disease and sepsis at the same time
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- clinical diagnosis of SALI
- must take liver support
Exclusion Criteria
- SALI
- Thyroid disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method prevelance, predictors and outcome of sepsis associated liver injury (SALI) baseline analysis outcome of sepsis associated liver injury (SALI)
28 days mortality baseline patient with liver dieases and sepsis
patient shouldn't be in pain baseline patient in study not in pain
- Secondary Outcome Measures
Name Time Method patient stay in hospital 2weeks baseline patient with liver dieases and sepsis
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link sepsis-induced inflammation to liver injury in SALI patients?
Which biomarkers predict severity and mortality in sepsis-associated liver injury (SALI) cases?
How does concurrent liver disease modify the clinical outcomes of septic patients with SALI?
What are the comparative management strategies for SALI versus non-SALI sepsis in critical care?
Are there therapeutic targets emerging from NCT06758908 for mitigating SALI progression in sepsis?